Celldex Therapeutics Inc (NASDAQ:CLDX)

Friday’s trading has closed, but CLDX is being traded in the after-hours session. After-Hours quote »
12.96
Data as of 4:00pm ET
 -0.13 / -0.99%
Today’s Change
10.76
Today|||52-Week Range
38.84
-46.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.2B

Company Description

Celldex Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. Its lead drug candidates include rindopepimut, glembatumumab vedotin and varlilumab. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Contact Information

Celldex Therapeutics, Inc.
Perryville III Building
Hampton New Jersey 08827
P:(908) 200-7500
Investor Relations:
(781) 433-3148

Employees

Shareholders

Mutual fund holders58.18%
Other institutional31.72%
Individual stakeholders0.36%

Top Executives

Anthony S. MarucciPresident, Chief Executive Officer & Director
Avery W. CatlinCFO, Secretary, Treasurer & Senior Vice President
Tibor KelerChief Scientific Officer & Executive VP
Thomas Andrew DavisChief Medical Officer & Executive Vice President
Ronald A. PepinChief Business Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.